| 臺大學術典藏 |
2021-09-02T00:04:01Z |
Unusual anisotropy of inplane field magnetoresistance in ultra-high mobility SiGe/Si/SiGe quantum wells
|
Melnikov M.Y;Dolgopolov V.T;Shashkin A.A;Huang S.-H;Liu C.W;Kravchenko S.V.; Melnikov M.Y; Dolgopolov V.T; Shashkin A.A; Huang S.-H; Liu C.W; Kravchenko S.V.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:04:01Z |
Valley effects on the fractions in an ultrahigh mobility SiGe/Si/SiGe two-dimensional electron system
|
Dolgopolov V.T;Melnikov M.Y;Shashkin A.A;Huang S.-H;Liu C.W;Kravchenko S.V.; Dolgopolov V.T; Melnikov M.Y; Shashkin A.A; Huang S.-H; Liu C.W; Kravchenko S.V.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:57Z |
Metallic state in a strongly interacting spinless two-valley electron system in two dimensions
|
Melnikov M.Y;Shashkin A.A;Dolgopolov V.T;Huang S.-H;Liu C.W;Zhu A.Y.X;Kravchenko S.V.; Melnikov M.Y; Shashkin A.A; Dolgopolov V.T; Huang S.-H; Liu C.W; Zhu A.Y.X; Kravchenko S.V.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:55Z |
Fractional Quantum Hall Effect in SiGe/Si/SiGe Quantum Wells in Weak Quantizing Magnetic Fields
|
Dolgopolov V.T;Melnikov M.Y;Shashkin A.A;Huang S.-H;Liu C.W;Kravchenko S.V.; Dolgopolov V.T; Melnikov M.Y; Shashkin A.A; Huang S.-H; Liu C.W; Kravchenko S.V.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:55Z |
Indication of band flattening at the Fermi level in a strongly correlated electron system
|
Melnikov M.Y;Shashkin A.A;Dolgopolov V.T;Huang S.-H;Liu C.W;Kravchenko S.V.; Melnikov M.Y; Shashkin A.A; Dolgopolov V.T; Huang S.-H; Liu C.W; Kravchenko S.V.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:52Z |
Effective g factor of low-density two-dimensional holes in a Ge quantum well
|
Lu T.M;Harris C.T;Huang S.-H;Chuang Y;Li J.-Y;Liu C.W.; Lu T.M; Harris C.T; Huang S.-H; Chuang Y; Li J.-Y; Liu C.W.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:51Z |
Density-controlled quantum Hall ferromagnetic transition in a two-dimensional hole system
|
Lu T.M;Tracy L.A;Laroche D;Huang S.-H;Chuang Y;Su Y.-H;Li J.-Y;Liu C.W.; Lu T.M; Tracy L.A; Laroche D; Huang S.-H; Chuang Y; Su Y.-H; Li J.-Y; Liu C.W.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-02T00:03:49Z |
Atomic-layer doping of SiGe heterostructures for atomic-precision donor devices
|
Bussmann E;Gamble J.K;Koepke J.C;Laroche D;Huang S.H;Chuang Y;Li J.-Y;Liu C.W;Swartzentruber B.S;Lilly M.P;Carroll M.S;Lu T.-M.; Bussmann E; CHEE-WEE LIU et al. |
| 臺大學術典藏 |
2021-08-27T06:48:51Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; KUAN-YIN LIN; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:51Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Cheng A.; KUAN-YIN LIN; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan
|
Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:48Z |
Public health intervention strategies to contain hepatitis a outbreaks
|
KUAN-YIN LIN; Lee Y.-L.; Huang S.-H.; Chen G.-J.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:48Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; KUAN-YIN LIN; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:09Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Cheng A.; KUAN-YIN LIN; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:08Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; KUAN-YIN LIN; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:08Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan
|
Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:05Z |
Public health intervention strategies to contain hepatitis a outbreaks
|
KUAN-YIN LIN; Lee Y.-L.; Huang S.-H.; Chen G.-J.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:04Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; KUAN-YIN LIN; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; YU-SHAN HUANG; Cheng A.; Lin K.-Y.; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:31Z |
Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan
|
Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; YU-SHAN HUANG; Lin K.-Y.; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:31Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
YU-SHAN HUANG; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:30Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; YU-SHAN HUANG; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Lin K.-Y.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-23T23:47:19Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang W.-C.; Huang C.-K.; Huang S.-H.; Lin S.-W.; Ou S.-T.; YI-TING CHEN; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-23T07:09:04Z |
Mobile health app with social media to support self-management for patients with chronic kidney disease: Prospective randomized controlled study
|
Li W.-Y.; Chiu F.-C.; Zeng J.-K.; Li Y.-W.; Huang S.-H.; Yeh H.-C.; Cheng B.-W.; FENG-JUNG YANG |
| 臺大學術典藏 |
2021-08-23T01:36:06Z |
Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus
|
Chuang L.-M.; Jou T.-S.; Yang W.-S.; HUEY-PEIR WU; Huang S.-H.; Tai T.-Y.; Lin B.J. |
| 臺大學術典藏 |
2021-08-20T07:38:58Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; SZU-MIN HSIEH; Sheng W.-H.; Chuang Y.-C.; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:54Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; YU-CHUNG CHUANG; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:53Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; Lin S.-W.; YU-CHUNG CHUANG; Sun H.-Y.; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:56Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; HSIN-YUN SUN; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; HSIN-YUN SUN; Chang S.-Y.; Cheng A.; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:54Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; Lin S.-W.; Chuang Y.-C.; HSIN-YUN SUN; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T04:24:47Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; Lin S.-W.; Chuang Y.-C.; Sun H.-Y.; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-19T03:49:01Z |
Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus
|
Chuang L.-M.; TZUU-SHUH JOU; Yang W.-S.; Wu H.-P.; Huang S.-H.; Tai T.-Y.; Lin B.J. |
| 臺大學術典藏 |
2021-08-16T08:36:17Z |
Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection
|
Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; ARISTINE CHENG; Lin K.-Y.; Huang Y.-C.; Chen G.-J.; Huang S.-H.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:15Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; ARISTINE CHENG; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:12Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; ARISTINE CHENG; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:12Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; ARISTINE CHENG; Lin K.-Y.; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-05T02:41:19Z |
Comprehending the causes of presence of copper and common heavy metals in sediments of irrigation canals in Taiwan
|
Huang S.-H;Chang T.-C;Chien H.-C;Wang Z.-S;Chang Y.-C;Wang Y.-L;Hsi H.-C.; Huang S.-H; Chang T.-C; Chien H.-C; Wang Z.-S; Chang Y.-C; Wang Y.-L; Hsi H.-C.; HSING-CHENG HSI |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma - Molecular basis and predicting favorable outcome
|
Kuo K.-T.; Hsiao C.-H.; CHING-HUNG LIN; Kuo L.-T.; Huang S.-H.; Lin M.-C. |
| 臺大學術典藏 |
2021-07-26T09:45:12Z |
An automatic microfluidic DNA microarray platform for SNP detection using a DNA intercalating dye and graphene oxide
|
Huang S.-H;Chang Y.-S;Chang K.-W;Tsai M.-H;Huang N.-T.; Huang S.-H; Chang Y.-S; Chang K.-W; Tsai M.-H; Huang N.-T.; MONG-HSUN TSAI |
